Scan before treatment could tell doctors if cancer therapy will work
NCT ID NCT07208487
Summary
This study looked back at 41 cancer patients to see if a special type of scan (a PET/CT) taken before treatment could predict how well a therapy involving implanted radioactive seeds would work. Researchers found that one specific measurement from the scan, called Metabolic Tumor Volume (MTV), was the best predictor. A higher MTV was linked to a worse outcome, meaning this scan could help doctors decide if this treatment is the right choice for a patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
Conditions
Explore the condition pages connected to this study.